A comprehensive view of Drug Delivery/Ingestion. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
American Regent launches FDA-approved injectable Atropine Sulfate; drug serves as temporary blockade of severe, life-threatening muscarinic effects, as an organophosphorus, muscarinic mushroom poisoning antidote, and to treat bradyasystolic cardiac arrest
Published:
August 10, 2022
by PR Newswire
|
Assure Infusions building 60,000 square-foot, fully automated IV fluid manufacturing plant in Bartow, Florida, to open in 2023; Assure launched in 2022 to make sterile IV fluids such as dextrose, Ringer’s lactate, normal saline, sterile water
Published:
August 10, 2022
by Business Wire
|
Aptar Pharma acquires worldwide license for Orbital Dry Powder Inhaler from Pharmaxis for undisclosed amount; high payload Orbital technology delivers up to 400 mg of powders in divided doses without the need to reload
Published:
August 10, 2022
by AptarGroup Inc.
|
Amgen acquiring biopharmaceutical firm ChemoCentryx for US$3.7B, with deal to close in Q4 2022; ChemoCentryx’s drugs include oral Tavneos to treat severe active ANCA-associated vasculitis and three candidates to treat inflammatory diseases, cancer
Published:
August 10, 2022
by Marketline - Deals
|
FDA to conduct clinical trial of Siga Technologies’ Tpoxx tecovirimat oral and injectable antiviral as a treatment for monkeypox; CDC reports 7,510 monkeypox cases in US
Published:
August 09, 2022
by SeeNews Pharmaceuticals
|
Ask us about our Tissue & Hygiene market view
Trending Chart
Interactive chart with headline count